Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Ionuț Pavel (Iași, Romania), Ionut Pavel, Ina Iuliana Macovei, Simona Péter, Daniela Diculencu, Florin Rusu-Cordunean, Bogdan Dragos Grigoriu. Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS). Eur Respir J 2016; 48: Suppl. 60, 1910

Member's Comments

No comment yet.

Related content which might interest you: Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing. Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Molecular fingerprinting of mycobacterium tuberculosis isolates in new cases of tuberculosis using mycobacterial interspersed repetitive unit–variable number tandem repeat genotyping (MIRU-VNTR) – Epidemiology of drug resistant tuberculosis in Greece Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Detection of fluoroquinolone resistance associated mutations in Mycobacterium tuberculosis by use of sequencing and TaqMan probes Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Side effect profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Genotypes of mycobacterium tuberculosis with pre-extended drug resistance in Belarus Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 23S rRNA mutations in linezolid-resistant clinical isolates of M. tuberculosis: A report of two cases Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Line probe assay (LiPA) based rapid detection of multiple drug resistent (MDR) mycobacterium tuberculosis (MTB) Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Molecular characterization of M. tuberculosis complex strains from a drug resistance survey in Albania Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Bioinformatics approach identified of novel genes of tuberculosis susceptibility Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012) Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Whole genome-sequencing of non-tuberculous mycobacteria Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak Source: Eur Respir J, 51 (6) 1702313; 10.1183/13993003.02313-2017 Year: 2018 Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017